Market Cap | ₹26Cr |
ROE | -18.19% |
P/E Ratio(TTM) | -16.15 |
EPS(TTM) | -2.34 |
P/B Ratio | 5.74 |
Dividend Yield | 0.00% |
Industry P/E | 40.67 |
Book Value | 6.59 |
Debt to Equity | 0.00 |
Face Value | 10 |
Parent Organisation | Phaarmasia Limited |
Managing Director | Mr. Maneesh Sapte |
BSE Symbol | 523620 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 112.63 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.37 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.43 | ||
Wockhardt | NA (0.00%) | -199.68 |